» Articles » PMID: 18378209

Vascular Endothelial Growth Factor Gene Polymorphisms in Age-related Macular Degeneration

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 2008 Apr 2
PMID 18378209
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate vascular endothelial growth factor (VEGF) gene polymorphisms in unrelated Taiwan Chinese patients with late age-related macular degeneration (AMD) and controls.

Design: Retrospective case-control study.

Methods: We enrolled 190 late AMD patients and 180 age-matched and gender-matched controls. Late AMD was classified as either dry (atrophic; grade 4) or wet (neovascular; grade 5) according to the International Age-Related Maculopathy Epidemiologic Study. Genomic deoxyribonucleic acid was prepared from peripheral blood obtained from all subjects. Polymerase chain reactions were used to analyze five candidate single-nucleotide polymorphisms (SNPs) in VEGF gene: +405C/G (rs2010963), -460 T/C (rs833061), +674 C/T (rs1413711), +936C/T (rs3025039), and -2578C/A (rs699947).

Results: Of the 190 late AMD patients, dry AMD was diagnosed in 104 and wet AMD in 86. Among the five candidate SNPs studied, only the +936 C/T was significantly associated with wet AMD (T allele: 30% in wet AMD vs 14% in controls; P = 1.45 x 10(-5); odds ratio, 2.61; 95% confidence interval, 1.68 to 4.07). No single haplotype was significantly associated with either late AMD or controls. Based on genotypes at both VEGF +936 C/T and the complement factor H (CFH) Y402H (rs1061170), the association of VEGF +936 C/T to AMD was significant when analyzed conditional on the presence of the CFH C risk allele and vice versa (P < .0001). The VEGF +936 C/T was in strong linkage disequilibrium with CFH Y402H (D' = 0.99).

Conclusions: Both VEGF +936 C/T and CFH Y402H polymorphisms are dependently associated with wet AMD in the Taiwan Chinese population.

Citing Articles

The interactions between , , and environmental factors on the risk of age-related macular degeneration.

Altankhuyag A, Ganbold C, Byambadorj B, Tumurbaatar S, Sodnomtseren P, Davaatseren U Mol Vis. 2025; 30:320-335.

PMID: 39959171 PMC: 11829785.


Exudative Age-Related Macular Degeneration: Association between Treatment Efficacy and Single-Nucleotide Variants in , , , , , , and Genes.

Vilkeviciute A, Cebatoriene D, Kriauciuniene L, Zaliuniene D, Liutkeviciene R Int J Mol Sci. 2024; 25(13).

PMID: 38999967 PMC: 11241034. DOI: 10.3390/ijms25136859.


Immunogenetic and Environmental Factors in Age-Related Macular Disease.

Brodzka S, Baszynski J, Rektor K, Holderna-Bona K, Stanek E, Kurhaluk N Int J Mol Sci. 2024; 25(12).

PMID: 38928273 PMC: 11203563. DOI: 10.3390/ijms25126567.


Haplotype and VEGF-A and VEGF-R2 Protein Associations with Exudative Age-Related Macular Degeneration.

Vilkeviciute A, Cebatoriene D, Kriauciuniene L, Liutkeviciene R Cells. 2022; 11(6).

PMID: 35326447 PMC: 8947491. DOI: 10.3390/cells11060996.


The omnipresence of vascular endothelial growth factor in retinal diseases.

Wu L Taiwan J Ophthalmol. 2020; 9(4):213-215.

PMID: 31942425 PMC: 6947743. DOI: 10.4103/tjo.tjo_73_19.